Nina Capital Holdings Inc. Acquires 12,500 Shares of PetMed Express, Inc. (NASDAQ:PETS) Stock

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) major shareholder Nina Capital Holdings Inc. purchased 12,500 shares of the stock in a transaction on Monday, September 9th. The shares were acquired at an average cost of $3.34 per share, with a total value of $41,750.00. Following the transaction, the insider now directly owns 2,078,000 shares in the company, valued at $6,940,520. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.

PetMed Express Trading Up 0.3 %

Shares of PETS stock traded up $0.01 during midday trading on Friday, reaching $3.98. 84,341 shares of the stock were exchanged, compared to its average volume of 340,601. PetMed Express, Inc. has a 1 year low of $2.90 and a 1 year high of $10.53. The company's 50 day moving average is $3.49 and its two-hundred day moving average is $3.91. The firm has a market cap of $81.99 million, a PE ratio of -23.41 and a beta of 0.71.

PetMed Express (NASDAQ:PETS - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.30. PetMed Express had a negative return on equity of 3.44% and a negative net margin of 1.24%. The firm had revenue of $67.95 million for the quarter, compared to the consensus estimate of $77.52 million. As a group, equities analysts expect that PetMed Express, Inc. will post 0.08 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Lake Street Capital reaffirmed a "hold" rating and set a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a research report on Wednesday, August 7th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Point72 DIFC Ltd purchased a new position in shares of PetMed Express during the 2nd quarter worth approximately $34,000. Oak Thistle LLC purchased a new position in shares of PetMed Express during the 1st quarter worth approximately $50,000. Marshall Wace LLP purchased a new stake in shares of PetMed Express in the 2nd quarter worth approximately $46,000. SG Americas Securities LLC purchased a new stake in shares of PetMed Express in the 2nd quarter worth approximately $46,000. Finally, Pinnacle Wealth Planning Services Inc. purchased a new stake in shares of PetMed Express in the 1st quarter worth approximately $61,000. Hedge funds and other institutional investors own 73.33% of the company's stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.